UCB, a Belgian biopharmaceutical company, has announced the divestment of its mature neurology and allergy portfolio in China for $680 million, marking a strategic shift towards innovation and partnerships in one of the world’s fastest-growing pharmaceutical markets. This significant deal involves the sale of well-known products such as Keppra, Vimpat, Neupro, Zyrtec, and Xyzal, along […]
Novocuff, Inc., has successfully closed an oversubscribed $26 million Series A funding round to advance their mission of improving pregnancy outcomes and reducing the incidence of preterm births. This significant financial milestone follows an initial seed round of $2 million. AXA IM Alts, a leader in global healthcare investments, spearheaded the funding with a substantial […]
In a significant move to bolster its unique financial services tailored for medical professionals, Earned Wealth, a leading tech-enabled financial services firm, has successfully secured a $200 million capital commitment. This funding round was led by growth equity investors Summit Partners and Silversmith Capital Partners, with continued support from existing investors such as Juxtapose, Hudson […]
Triton Pacific Healthcare Partners, a notable healthcare-focused private equity group, has successfully concluded the sale of BioMatrix Specialty Infusion Pharmacy to Frazier Healthcare Partners. While the terms of the transaction remain undisclosed, Triton Pacific achieved a significant return of 3.0x on its investment. Since acquiring BioMatrix in 2016, Triton Pacific has played a pivotal role […]
Cipla Limited has announced an additional investment of EUR 3 million in Ethris GmbH, further strengthening its involvement in the mRNA technology sector. This move follows an initial investment of EUR 15 million in 2022 and underscores Cipla’s commitment to advancing mRNA-based treatments, particularly for patients in emerging markets. Ethris, recognized as a leader in […]
Fischer Medical Ventures Ltd, formerly known as Fischer Chemic Limited, has formalized its investment in the Singapore-based Wonder Tech Group, marking a significant step in the advancement of mental healthcare through innovative AI-driven solutions. This partnership underscores Fischer Medical Ventures’ commitment to enhancing mental health diagnostics and treatment through cutting-edge technology. Wonder Tech has developed […]
Shore Capital Partners, a private equity firm based in Chicago known for its focus on microcap investments, has successfully completed the sale of Behavioral Innovations to Tenex Capital Management. Behavioral Innovations, a prominent provider of center-based applied behavior analysis (ABA) therapy, caters to early intervention children with autism spectrum disorder and related developmental disabilities, operating […]
In a significant move to enhance its immunology offerings, Johnson & Johnson (NYSE: JNJ) has announced a definitive agreement to acquire a wholly-owned subsidiary of Numab Therapeutics, gaining global rights to an investigational bispecific antibody, NM26. The deal, valued at approximately $1.25 billion, is poised to transform treatment paradigms in atopic dermatitis (AD) and potentially […]
In a significant development within the medical technology sector, KKR, a prominent global investment firm, has agreed to purchase a controlling stake in Healthium Medtech Ltd., an Indian leader in medical devices, from Apax Partners LLP, a global private equity advisory firm. This transaction, managed by a special purpose vehicle owned by KKR-managed funds, marks […]
AstraZeneca PLC has reported a notable performance in the first quarter of 2024, with total revenue reaching $12,679 million, marking a 19% increase at constant exchange rates (CER). The increase was primarily driven by an 18% rise in product sales, bolstered by significant growth in alliance revenue, which surged by 59% at CER. The company […]